Tilianin Protects against Ischemia/Reperfusion-Induced Myocardial Injury through the Inhibition of the Ca2+/Calmodulin-Dependent Protein Kinase II-Dependent Apoptotic and Inflammatory Signaling Pathways.

Abstract

Tilianin is a naturally occurring phenolic compound with a cardioprotective effect against myocardial ischemia/reperfusion injury (MIRI). The aim of our study was to determine the potential targets and mechanism of action of tilianin against cardiac injury induced by MIRI. An in silico docking model was used in this study for binding mode analysis between tilianin and Ca2+/calmodulin-dependent protein kinase II (CaMKII). Oxygen-glucose deprivation/reperfusion- (OGD/R-) injured H9c2 cardiomyocytes and ischemia/reperfusion- (I/R-) injured isolated rat hearts were developed as in vitro and ex vivo models, respectively, which were both treated with tilianin in the absence or presence of a specific CaMKII inhibitor KN93 for target verification and mechanistic exploration. Results demonstrated the ability of tilianin to facilitater the recovery of OGD/R-induced cardiomyocyte injury and the maintenance of cardiac function in I/R-injured hearts. Tilianin interacted with CaMKIIδ with an efficient binding performance, a favorable binding score, and restraining p-CaMKII and ox-CaMKII expression in cardiomyocytes injured by MIRI. Importantly, inhibition of CaMKII abolished tilianin-mediated recovery of OGD/R-induced cardiomyocyte injury and maintenance of cardiac function in I/R-injured hearts, accompanied by the disability to protect mitochondrial function. Furthermore, the protective effects of tilianin towards mitochondrion-associated proapoptotic and antiapoptotic protein counterbalance and c-Jun N-terminal kinase (JNK)/nuclear factor- (NF-) κB-related inflammation suppression were both abolished after pharmacological inhibition of CaMKII. Our investigation indicated that the inhibition of CaMKII-mediated mitochondrial apoptosis and JNK/NF-κB inflammation might be considered as a pivotal mechanism used by tilianin to exert its protective effects on MIRI cardiac damage.

• Authors: Hailun Jiang, Jianguo Xing, Jiansong Fang, Linlin Wang, Yu Wang, Li Zeng, Zhuorong Li, Rui Liu
• Journal: BioMed research international (Biomed Res Int) Vol. 2020 Pg. 5939715 ( 2020) ISSN: 2314-6141 [Electronic] United States
• PMID: 33102583 (Publication Type: Journal Article)
• Copyright: Copyright © 2020 Hailun Jiang et al.

Chemical References

• Flavonoids
• Glycosides
• NF-kappa B
• Protective Agents
• tilianin
• Calcium-Calmodulin-Dependent Protein Kinase Type 2

Topics

• Animals
• Apoptosis (drug effects)
• Calcium-Calmodulin-Dependent Protein Kinase Type 2 (metabolism)
• Cell Line
• Flavonoids (pharmacology)
• Glycosides (pharmacology)
• Inflammation (drug therapy, metabolism)
• Mitochondria (drug effects, metabolism)
• Myocardial Reperfusion Injury (drug therapy, metabolism)
• Myocardium (metabolism)
• Myocytes, Cardiac (drug effects, metabolism)
• NF-kappa B (metabolism)
• Protective Agents (pharmacology)
• Rats
• Signal Transduction (drug effects)